Evidence map›Paper›PMID 38952208›Full record

ArticleACS nano2024

A Self-Cascade Penetrating Brain Tumor Immunotherapy Mediated by Near-Infrared II Cell Membrane-Disrupting Nanoflakes via Detained Dendritic Cells.

Bhanu Nirosha Yalamandala, Yu-Jen Chen, Ya-Hui Lin, Thi My Hue Huynh, Wen-Hsuan Chiang, Tsu-Chin Chou, Heng-Wei Liu, Chieh-Cheng Huang, Yu-Jen Lu, Chi-Shiun Chiang and 2 more

Abstract read
In one paragraph

Article in ACS nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.Signal transduction and targeted therapy · 2026
    Article
  12. Article
  13. Advancing brain immunotherapy through functional nanomaterials.Drug delivery and translational research · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bhanu Nirosha YalamandalaDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.
Yu-Jen ChenDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.
Ya-Hui LinDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.
Thi My Hue HuynhDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.ORCID 0000-0003-1829-7554
Wen-Hsuan ChiangDepartment of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan.ORCID 0000-0002-2022-0858
Tsu-Chin ChouInstitute of Analytical and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.
Heng-Wei LiuDepartment of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
Chieh-Cheng HuangInstitute of Biomedical Engineering, National Tsing Hua University, Hsinchu 300044, Taiwan.ORCID 0000-0003-1773-8450
Yu-Jen LuDepartment of Neurosurgery, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan.
Chi-Shiun ChiangDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.
Li-An ChuDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.
Shang-Hsiu HuDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300044, Taiwan.ORCID 0000-0002-8965-3918

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunotherapy can potentially suppress the highly aggressive glioblastoma (GBM) by promoting T lymphocyte infiltration. Nevertheless, the immune privilege phenomenon, coupled with the generally low immunogenicity of vaccines, frequently hampers the presence of lymphocytes within brain tumors, particularly in brain tumors. In this study, the membrane-disrupted polymer-wrapped CuS nanoflakes that can penetrate delivery to deep brain tumors via releasing the cell-cell interactions, facilitating the near-infrared II (NIR II) photothermal therapy, and detaining dendritic cells for a self-cascading immunotherapy are developed. By convection-enhanced delivery, membrane-disrupted amphiphilic polymer micelles (poly(methoxypoly(ethylene glycol)-benzoic imine-octadecane, mPEG-

Indexed as

Brain NeoplasmsCell MembraneDendritic CellsImmunotherapyInfrared RaysAnimalsApoptosisCell Line, TumorGlioblastomaHumansMiceMicellesNanoparticlesPhotothermal TherapyPolyethylene GlycolsMicellesPolyethylene Glycolsbrain tumorCuS nanoflakesimmunoadjuvantimmunotherapyNIR IIpolymeric micelle

Identifiers

PMID38952208
PMCPMC11256899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.